DSIP

What It Is

A nine-amino-acid peptide originally isolated from cerebral venous blood of rabbits during electrically induced sleep. Studied across decades of literature for its neuromodulatory effects, with mechanisms that remain only partially characterized.

How It Works

DSIP enters circulation in the research model

→

Crosses the blood-brain barrier

→

Modulates central neurotransmitter systems

→

Slow-wave sleep architecture is investigated

What Researchers Study It For

Slow-wave sleep architecture studies

Stress-response and HPA-axis research

Neuropeptide signaling investigations

Chronobiology and circadian-rhythm models

Common Research Protocols

In published animal and early human studies, DSIP has been administered intravenously, intranasally, or subcutaneously, with protocols emphasizing low microgram-to-milligram per-kg dosing and timing relative to the sleep-wake cycle.

Community Interest Areas

The neuropeptide research community continues to study DSIP because, despite more than four decades of literature, its precise receptor target has not been definitively identified. This makes it a recurring subject in investigations of unconventional neuropeptide signaling, sleep-architecture modulation, and stress-axis dampening.

9 Amino Acids Nonapeptide originally isolated from cerebral venous blood

Multi-Decade Studied across 40+ years of peer-reviewed literature

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?